AU2013328280B2 - Ketamine derivatives - Google Patents

Ketamine derivatives Download PDF

Info

Publication number
AU2013328280B2
AU2013328280B2 AU2013328280A AU2013328280A AU2013328280B2 AU 2013328280 B2 AU2013328280 B2 AU 2013328280B2 AU 2013328280 A AU2013328280 A AU 2013328280A AU 2013328280 A AU2013328280 A AU 2013328280A AU 2013328280 B2 AU2013328280 B2 AU 2013328280B2
Authority
AU
Australia
Prior art keywords
compound
amino
chlorophenyl
oxocyclohexyl
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013328280A
Other languages
English (en)
Other versions
AU2013328280A1 (en
Inventor
William Alexander Denny
Swarnalatha Akuratiya Gamage
Martyn Gregory HARVEY
Jiney JOSE
James Wallace SLEIGH
Logan James VOSS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auckland Uniservices Ltd
Original Assignee
Auckland Uniservices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auckland Uniservices Ltd filed Critical Auckland Uniservices Ltd
Publication of AU2013328280A1 publication Critical patent/AU2013328280A1/en
Application granted granted Critical
Publication of AU2013328280B2 publication Critical patent/AU2013328280B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
AU2013328280A 2012-10-08 2013-10-08 Ketamine derivatives Ceased AU2013328280B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NZ602885 2012-10-08
NZ60288512 2012-10-08
NZ61120213 2013-05-28
NZ611202 2013-05-28
PCT/IB2013/059191 WO2014057414A1 (en) 2012-10-08 2013-10-08 Ketamine derivatives

Publications (2)

Publication Number Publication Date
AU2013328280A1 AU2013328280A1 (en) 2015-05-14
AU2013328280B2 true AU2013328280B2 (en) 2017-12-21

Family

ID=50476991

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013328280A Ceased AU2013328280B2 (en) 2012-10-08 2013-10-08 Ketamine derivatives

Country Status (13)

Country Link
US (3) US20150259277A1 (enExample)
EP (1) EP2903963A4 (enExample)
JP (2) JP6309957B2 (enExample)
KR (1) KR20150065873A (enExample)
CN (1) CN104837810B (enExample)
AU (1) AU2013328280B2 (enExample)
BR (1) BR112015007647A2 (enExample)
CA (1) CA2922340A1 (enExample)
EA (1) EA201590697A1 (enExample)
HK (1) HK1212673A1 (enExample)
IN (1) IN2015DN03854A (enExample)
MX (1) MX2015004362A (enExample)
WO (1) WO2014057414A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201590697A1 (ru) * 2012-10-08 2015-09-30 Окленд Юнисервисиз Лимитед Производные кетамина
US20160332962A1 (en) * 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
AU2016288188B2 (en) 2015-06-27 2021-08-05 Shenox Pharmaceuticals, Llc Ketamine transdermal delivery system
US11827606B2 (en) 2015-11-18 2023-11-28 Spirify Pharma Inc. Phenyl cyclohexanone derivatives and methods of making and using them
US11111210B2 (en) 2015-11-18 2021-09-07 Spirify Pharma Inc. Phenyl cyclohexanone derivatives and methods of making and using them
AU2017238859B2 (en) 2016-03-25 2021-02-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
KR20260028033A (ko) 2018-01-10 2026-03-03 엑스더블유파마 리미티드 케타민의 전구약물, 및 이의 조성물 및 용도
WO2019186357A1 (en) * 2018-03-26 2019-10-03 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases
CA3102387A1 (en) * 2018-06-04 2019-12-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Process for synthesis and purification of (2r,6r)-hydroxynorketamine
CN112125816A (zh) * 2020-03-17 2020-12-25 国药集团工业有限公司 一种氯胺酮、其衍生物或其盐的消旋化方法
DE102021105268A1 (de) * 2021-03-04 2022-09-08 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm
US11690811B2 (en) 2021-08-13 2023-07-04 XWPharma Ltd. Pharmaceutical compositions and oral dosage forms of ketamine derivatives
CN115677444A (zh) * 2022-10-26 2023-02-03 公安部第三研究所 同位素毒品代谢物标记化合物及其制备方法、用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004045601A1 (en) * 2002-11-18 2004-06-03 Yaupon Therapeutics, Inc. Analgesic uses of norketamine and ketamine/norketamine prodrugs

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254124A (en) * 1962-06-29 1966-05-31 Parke Davis & Co Aminoketones and methods for their production
GB1134146A (en) * 1967-09-15 1968-11-20 Parke Davis & Co New organic amines and methods for their production
US5019583A (en) 1989-02-15 1991-05-28 Glaxo Inc. N-phenyl-N-(4-piperidinyl)amides useful as analgesics
US5466700A (en) 1993-08-30 1995-11-14 Glaxo Wellcome Inc. Anesthetic use of N-phenyl-N-(4-piperidinyl)amides
US5866591A (en) 1996-09-11 1999-02-02 Glaxo Wellcome Inc. Stable formulations of remifentanil
JP2004501067A (ja) * 2000-01-28 2004-01-15 ローム　アンド　ハース　カンパニー 高められた特性をもつ医薬
US20040248963A1 (en) 2001-11-23 2004-12-09 Bueno Melendo Ana Belen Prodrugs of excitatory amino acids
ATE492565T1 (de) * 2002-01-31 2011-01-15 Randox Lab Ltd Immunogene, antikörper und konjugate für ketamin und dessen metaboliten
PT1928405E (pt) * 2005-09-28 2014-10-20 Auris Medical Ag Composições farmacêuticas para o tratamento de distúrbios do ouvido interno
CN101765582A (zh) * 2007-04-26 2010-06-30 奥斯拜客斯制药有限公司 氘标记的氯胺酮
CN104395283A (zh) 2011-10-14 2015-03-04 美国政府健康及人类服务部 (2r,6r)-羟基去甲氯胺酮、(s)-脱氢去甲氯胺酮以及(r,s)-氯胺酮的其他立体异构脱氢和羟基化代谢物在治疗忧郁症和神经性疼痛中的应用
EA201590697A1 (ru) * 2012-10-08 2015-09-30 Окленд Юнисервисиз Лимитед Производные кетамина

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004045601A1 (en) * 2002-11-18 2004-06-03 Yaupon Therapeutics, Inc. Analgesic uses of norketamine and ketamine/norketamine prodrugs

Also Published As

Publication number Publication date
WO2014057414A1 (en) 2014-04-17
KR20150065873A (ko) 2015-06-15
EP2903963A1 (en) 2015-08-12
CN104837810A (zh) 2015-08-12
US10239825B2 (en) 2019-03-26
AU2013328280A1 (en) 2015-05-14
IN2015DN03854A (enExample) 2015-10-02
CA2922340A1 (en) 2014-04-17
US20190169113A1 (en) 2019-06-06
CN104837810B (zh) 2019-08-06
EA201590697A1 (ru) 2015-09-30
WO2014057414A9 (en) 2014-12-18
BR112015007647A2 (pt) 2017-07-04
EP2903963A4 (en) 2016-05-25
HK1212673A1 (zh) 2016-06-17
JP6309957B2 (ja) 2018-04-11
US20170190653A1 (en) 2017-07-06
US20150259277A1 (en) 2015-09-17
JP2018127466A (ja) 2018-08-16
MX2015004362A (es) 2015-12-08
JP2015535847A (ja) 2015-12-17

Similar Documents

Publication Publication Date Title
US10239825B2 (en) Ketamine derivatives
AU2008259841B2 (en) Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
KR20220131520A (ko) 아릴시클로헥실아민 유도체 및 정신장애 치료에서의 이의 용도
JP6041886B2 (ja) オピオイド受容体の調節物質およびそれを含む薬学的組成物
AU2020206826B2 (en) Ketamine pamoate and use thereof
EP0779284A1 (fr) Nouveaux dérivés de 2-naphthamides et leurs applications thérapeutiques comme agonistes des récepteurs D3
EA036954B1 (ru) Ксантинзамещенные алкинилкарбаматы/обращенные карбаматы в качестве антагонистов a2b
HU199440B (en) Process for producing morpholine derivatives and pharmaceutical compositions comprising the compounds
JP6321274B2 (ja) トリプル再取込み阻害剤及びそれらの使用方法
CN109071392A (zh) 苯环衍生物及其制备方法和在医药上的应用
CN101223129A (zh) 高度选择性血清素和去甲肾上腺素双重再摄取抑制剂和其用途
DE2748466A1 (de) 4a-aryloctahydro-1h-2-pyrindine
NZ619257B2 (en) Ketamine derivatives
HUE024560T2 (hu) Pantenil-dokozahexanoát, valamint ennek alkalmazása szív-érrendszeri betegségek kezelésére és megelõzésére
DE60312511T2 (de) Oxophenylcyclohexylpropanolaminderivate, deren herstellung und verwendung in therapeutika
US8455550B2 (en) Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products
RU2860311C2 (ru) Ингибитор мутанта idh и его применение
JP2023537087A (ja) 長時間作用性の低嗜癖性の化合物及びその調製方法
JP7579595B2 (ja) 長時間作用性の低嗜癖性ｈｎｋ誘導体及びその製造方法
US8669250B2 (en) Derivatives of aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl}-methanone, their method of preparation and their use as medicinal products
JP2018526387A (ja) 疼痛のための治療化合物及びその合成
JPH06100509A (ja) シクロペンテノン化合物及び該化合物を有効成分とする脳機能改善薬
WO2019099760A1 (en) Aryl-substituted acetamide and pyrrolidin-2-one derivatives and their use for the treatment of seizures
WO2018030382A1 (ja) モルヒナン誘導体
EP0998469A1 (fr) Cycloalkyles benzamides stimulants de la motricite gastrointestinale haute et basse

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired